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Objective: to determine if the frequency of a1AT deficiency (PiZ) is increased in patients with abdominal aortic aneurysm
(AAA), and, to investigate whether aneurysmal stiffness and other clinical characteristics differ in AAA patients with
and without a1AT deficiency.
Methods: we identified a1AT-deficient individuals by a monoclonal-antibody ELISA technique, in 102 consecutive
patients with AAA. Positive ELISA samples were further phenotyped by isoelectric focusing to differentiate between the
heterozygosity (PiZ) and homozygosity (PiZZ) state. Aneurysmal diameter and stiffness was measured using echotracking
sonography and blood pressure measurements.
Results: the frequency of heterozygous a1AT deficiency (PiZ) in patients with AAA was similar to that in the general
population (6.8% and 4.7%, respectively, p>0.3). The frequency of popliteal and femoral aneurysm was similar in male
PiZ-carriers and non-carriers with AAA, as were age at diagnosis of AAA, aneurysmal diameter, aneurysmal stiffness,
and presence of factors that may be associated with AAA (i.e. smoking, hypertension, diabetes mellitus, and family history
of AAA). Occurrence of ischaemic heart disease was more frequent in male non-PiZ-carriers than in male PiZ-carriers
with AAA (p=0.03).
Conclusions: the frequency of a1AT deficiency (PiZ) was not increased in our series of patients with AAA and patients
in whom the two disorders coexisted did not appear to have different clinical characteristics except for the lower occurrence
of ischaemic heart disease among the PiZ-carriers.
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Introduction circulating protease inhibitor (Pi).11 It is an acute phase
glycoprotein synthesised mainly in the liver and in-
hibits a broad variety of serine proteases releasedThe pathogenesis of abdominal aortic aneurysms
by activated neutrophils, including elastase.12 a1AT is(AAA) is probably multifactorial. Reports of familial
characterised by considerable genetic variation, moreclustering of AAA and the male predominance in most
than 70 genetic variants (Pi types) having been re-cases suggest a significant genetic component in the
cognised. The most common deficiency variant, PiZ,pathogenesis of aneurysms.1,2 There are also sug-
predisposes to emphysema,13 chronic liver disease,14gestions that AAA may be a manifestation of a systemic
and systemic vasculitis.15–18 In the Swedish population,abnormality.3–6 The balance between serine proteases
the frequency of homozygosity (PiZZ) has been re-and their inhibitors is important in maintaining tissue
ported to be 0.057%, and that of PiZ heterozygosityintegrity and several investigators have proposed that
4.7%.13alpha1-antitrypsin (a1AT) deficiency may be one pa-
In the last few years, conflicting data on the as-thogenetic factor in the development of AAA. Neutro-
sociation between AAA and a1AT deficiency havephil elastase activity has been found to be increased
been reported.19–21 Recently, we studied patients within aneurysmal tissue.7,8 Low a1AT concentration,9 and
homozygous a1AT deficiency and found that the ab-a significant alteration of the balance between a1AT
dominal aortic diameter in patients with a1AT de-and neutrophil elastase at the tissue level,10 have been
ficiency did not differ compared to controls.22 Aorticfound in patients with AAA. a1AT is the most abundant
distensibility in men with a1AT deficiency was, how-
ever, altered which may reflect early vessel wall ab-
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normality.22 The purpose of this study was to definepartment of Clinical Physiology, University of Lund, Malmo¨ Uni-
versity Hospital, S-205 02 Malmo¨, Sweden. the prevalence of a1AT deficiency in a large group of
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Swedish patients with AAA and to investigate whether sonography.26,27 We used an ultrasound echo-tracking
system (Diamove, Teltec AB, Lund, Sweden) interfacedaneurysmal stiffness and other clinical characteristics
differ in AAA patients with a1AT deficiency. with a real-time ultrasound scanner (EUB 240, Hitatchi,
Tokyo, Japan) and fitted with a 3.5 and 5 MHz linear
array transducer,28 capable of detecting vessel wall
movements <10 lm.28,29 With this equipment pulsatilePatients and Methods
vessel diameter changes can be measured and, in
combination with blood pressure measurements, formThe total cohort comprised 102 unrelated consecutive
the basis for calculation of vessel wall stiffness.30 De-patients with AAA (83 males, 19 females; mean age,
tails of the technique have previously been de-73–8 years). All known AAA in Malmo¨ are regularly
scribed.31–33 In short, the aorta was visualised in afollowed by ultrasonography at the Department of
longitudinal section on the real time image. AneurysmClinical Physiology, University Hospital, Malmo¨, Swe-
diameter and diameter changes were recorded at theden. Of these, 98 consecutive patients were included
maximal anteroposterior diameter of the aneurysm.in this study. In addition, during the study period,
From each registration a sequence of at least fivefour previously undiagnosed patients with AAA were
representative consecutive diameter cycles was manu-operated upon and blood samples for phenotyping
ally chosen and the aortic diameters and the diameterwere taken in conjunction with the operation. AAA
changes calculated as means of the selected diameterwas defined as an aortic diameter[30 mm and/or an
cycles. Indirect blood pressure measurements wereisolated dilatation of the infrarenal aorta with the
performed immediately after measurements of themorphological appearance of an aneurysm.23 At the
pulsatile aortic diameter with a sphygmomanometertime of the ultrasound examination, a medical history
and a standard cuff on the left upper arm. Each subjectwas obtained including smoking habits and presence
was examined three times with calculation of meanof hypertension, diabetes, ischaemic heart disease and
diameter and stiffness from the corresponding dia-family history of AAA.
meter, pulsatile diameter change, and blood pressures.
The average of the values for each subject were cal-
culated. The mean aneurysm diameter was defined as
Identification of PiZ-phenotype by ELISA procedure (Dmax+Dmin)/2. Mean arterial blood pressure was
taken as the diastolic pressure plus one-third of the
All serum samples were obtained from patients at the pulse pressure. Using this technique the variabilities
time of ultrasound examination and maintained at for repeated measurements of abdominal aortic an-
-20 °C until the time of analysis. Serum samples were eurysm diameter are 2–3%34 and for stiffness 18%.3
screened for the a1AT PiZ deficiency allele with a Popliteal aneurysm and femoral aneurysm were de-
previously described monoclonal antibody-ELISA fined as an isolated dilatation of the popliteal artery
technique.24 Briefly, a hybridoma cell line, ATZ 11, and the common femoral artery, respectively, with the
produced by fusion of spleen cells from BALB/c mice morphological appearance of an aneurysm.
immunised with a purified liver PiZ a1AT and Sp 2/0
Ag 14 mouse myeloma cells, was used to produce
monoclonal antibodies (IgG1) that interact specifically Statistical analysis
with PiZ a1AT. These antibodies were used in an ELISA
procedure permitting identification of PiZ variant. The Binominal test was used to compare the frequency of
test can not distinguish between the heterozygous and PiZ in the AAA population with that of the general
the homozygous state. As non-PiZ phenotypes lack population. The Chi-squared test was used to compare
absorbance in this test, they all emerge as negative. the proportions in different groups. If the requirements
Positive samples for PiZ variant by ELISA were further of this test were not fulfilled, Fischer’s exact test was
analysed by isoelectric focusing25 to differentiate be- used. Differences in clinical characteristics between
tween homozygosity (PiZZ) and heterozygosity (PiZ). groups were statistically tested with Mann–Whitney
U-test. p<0.05 was taken as significant.
Ultrasonic measurements of aortic diameter and
distensibility Results
Aortic aneurysm diameter and pulsatile diameter Table 1 shows the clinical characteristics of the studied
population of 102 AAA patients grouped according tochanges were measured by means of echo-tracking
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Table 1. Clinical characteristics in 102 patients with abdominal aortic aneurysm (AAA) grouped according to gender. All data, except
frequencies, are presented as mean–S.D.
Males Females p value
n=83 n=19
Age (range, years) 73–8 (53–91) 73–8 (56–84) NS
Length (cm) 177–7 164–6 —
Weight (kg) 77–11 62–10 —
Age at diagnosis (range, years) 71–8 (53–90) 71–9 (53–84) NS
AAA diameter (range, mm) 44–13 (25–99) 35–10 (22–60) p=0.004
Popliteal aneurysm 4/72 0/19 NS
Femoral aneurysm 4/72 0/19 NS
Smoking* 28/78 12/19 p=0.03
Hypertension** 33/80 9/19 NS
Diabetes† 4/80 0/19 NS
Family history of AAA‡ 10/55 2/14 NS
Ischaemic heart disease§ 34/80 3/19 p=0.036
* Smoking was defined as current smoker or ex-smoker since less than 1 year. **Hypertension was defined as requirement of anti-
hypertension medication. † Diabetes was defined as requirement of insulin or anti-diabetic medication. ‡ Eighteen men and five women
did not know and were therefore excluded from the calculation. § Ischaemic heart disease was defined as history of coronary heart disease
requiring medication.
Table 2. Clinical characteristics in males with abdominal aortic aneurysm (AAA) grouped according to presence of PiZ. All data,
except frequencies, are presented as mean–S.D.
Heterozygous PiZ Non-PiZ-carriers p value
n=6 n=77
Age (range, years) 74–13 (53–90) 72–7 (54–91) NS
Age at diagnosis (range, years) 73–13 (53–90) 71–7 (53–85) NS
AAA diameter (range, mm) 48–13 (35–68) 43–13 (25–99) NS
Popliteal aneurysm 1/5 3/67 NS
Femoral aneurysm 1/5 3/67 NS
Smoking 2/5 26/73 NS
Hypertension 4/6 29/74 NS
Diabetes 0/6 4/74 NS
Family history of AAA* 0/4 10/61 NS
Ischaemic heart disease 0/6 34/74 p=0.03
* Two PiZ-carriers and 16 non-PiZ-carriers did not know and were therefore excluded from the calculation.
gender. There were no significant differences between differences between the two groups in mean age at
diagnosis of AAA, aneurysmal diameter, associatedthe men and women in mean age at diagnosis, as-
sociated popliteal or femoral aneurysm, associated popliteal or femoral aneurysm, smoking habits, pres-
ence of hypertension or diabetes mellitus, or familyhypertension, diabetes mellitus or family history of
AAA (p>0.05 for all variables). The aneurysmal dia- history of AAA. Ischaemic heart disease was sig-
nificantly more frequent in non-PiZ-carriers than inmeter and occurrence of ischaemic heart disease were
significantly higher in male patients than in female PiZ-carriers (p=0.03).
Figure 1 shows stiffness of the AAA in male patientspatients (p=0.004 and p=0.036, respectively). In con-
trast, smoking was more frequent in female than in in relation to stiffness of the normal aorta in a pre-
viously published reference material.32 In the an-male AAA patients (p=0.03).
Seven (6.8%) of the AAA patients (six males and eurysm population male PiZ-carriers showed no
apparent differences in stiffness values compared withone female) were found to be PiZ heterozygotes, a
figure that is not statistically different from that re- the non-PiZ-carriers (p>0.05).
ported in the general Swedish population (4.7%)13
(p=0.30). No patient with AAA was found to be
homozygous (PiZZ) for a1AT deficiency. When ana-
lysing only male patients with an aneurysm diameter Discussion
[40 mm (n=49), there was still no increased fre-
quency of PiZ (p=0.2). The clinical characteristics of Aneurysmal pathogenesis seems to be complex and
heterogenous and several investigators have tried tothe male PiZ allele carriers (n=6) and non-carriers (n=
77) are presented in Table 2. There were no significant find a link between a1AT deficiency and the formation
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frequency of aneurysmal disease in 30 PiZZ in-
dividuals autopsied,20,38 and recently St. Jean and co-
workers found no evidence for an association between
the PiZ for a1AT deficiency and AAA in two separate
groups of patients from Pittsburgh, U.S.A. and from
London, U.K.21 In the present study of a series of
Swedish patients with AAA, the frequency of the PiZ
allele was not increased compared with that of a
general population of the same geographical origin.13
The frequency of the PiZ allele in the Swedish general
population13 used as a control group in the present
study was based on a large sample size and later
confirmed by a large screening of 200 000 Swedish
newborns.39
Several definitions of AAA are used at present,
which produces different results in evaluating the
incidence and prevalence of the disease. The definition




















evaluate if a1AT deficiency might be over-represented
in larger AAA, we also analysed only AAA withFig. 1. Stiffness of the abdominal aortic aneurysms in male PiZ-
carriers (E) and non-PiZ-carriers (A) in relation to the normal aorta diameter [40 mm. Even then the frequency of PiZ
in the reference population. The solid line represents mean and the allele was not increased. This is in agreement with thedotted lines represent upper and lower 95% confidence interval for
recent study of St. Jean et al. on patients with AAAthe reference population. There was no apparent difference in
stiffness between male PiZ-carriers and non-carriers with AAA. undergoing aneurysm repair.21 In the present study
the frequencies of popliteal and femoral aneurysms
seemed to be similar in male PiZ-carriers and non-
carriers with AAA, and there were no significantof AAA.19,35 There are several reasons for this. By
differences in age at diagnosis of AAA, aneurysmalinhibiting various proteolytic enzymes such as elast-
diameter, or presence of factors that may be associatedase, a1AT may have an important role in maintaining with AAA (i.e. smoking, hypertension, diabetes mel-the integrity of connective tissue, including the blood
litus, and family history of AAA). We recently studiedvessel wall. By disturbing the balance between pro-
patients with homozygous a1AT deficiency and foundteases and their inhibitors, a deficiency of a1AT the- that the abdominal aortic diameter did not differ com-oretically might affect the arterial wall. There are
pared to controls in the fairly young patients studied.22biochemical data supporting a systemic alteration in
The male individuals with a1AT deficiency had, how-elastin metabolism in patients with AAA.7,8,10 Reports
ever, significantly lower aortic stiffness values thanof familial aggregation of AAA1,2 and the male pre-
controls, which may indicate early vessel wall ab-dominance in most cases,2 suggest a significant genetic
normality. The wall of AAAs has been shown to becomponent of the pathogenesis of some aneurysms.
significantly stiffer in both males and females com-There are also clinical observations suggesting that
pared with the normal aortic wall in a reference popu-AAA may be a manifestation of a systemic abnormality
lation.3 In males with AAA, however, a wide range ofincluding the association between AAA and peripheral
stiffness values was found, with some AAA havinganeurysms,4 inguinal hernias,5 arteriomegaly,6 im-
low stiffness, suggesting that these individuals mightpaired lung function,35 and altered mechanical prop-
represent a subgroup of AAA with different aetiology,erties in non-aneurysmal parts of the vascular tree.3
with a1AT deficiency as one suggestion. In this study,Early reports on the concomitant occurrence of a1AT
however, the aneurysmal stiffness in heterozygousdeficiency and aneurysmal disease are based on a case
PiZ-carriers did not seem to differ compared to non-presentation36 and a study by Cohen and co-workers19
PiZ-carriers.on 47 patients with AAA, which suggested a higher
Our findings do not support a relationship betweenfrequency of a1AT deficiency in patients with AAA.
a1AT deficiency (PiZ) and the pathogenesis of AAA.There have also been reports indicating the possible
The putative association between a1AT deficiency andimportance of a1-antitrypsin deficiency for intracranial
AAA found by Cohen and co-workers19 might beaneurysms.37 In contrast, in a case-controlled autopsy
based study, we did not substantiate an increased the result of a selection bias. The recently reported
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